Search

Mark Player Phones & Addresses

  • 80 Page Ln, Phoenixville, PA 19460 (610) 650-0612
  • 5022 Swan Dr, Phoenixville, PA 19460

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Emails

m***o@bellatlantic.net

Resumes

Resumes

Mark Player Photo 1

Senior Scientific Director And Fellow At Janssen Pharmaceutical Research & Development

View page
Position:
Senior Scientific Director and Fellow at Janssen Pharmaceutical Research & Development
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
Janssen Pharmaceutical Research & Development since Apr 2002
Senior Scientific Director and Fellow

3-Dimensional Pharmaceuticals Jan 1997 - Apr 2002
Senior Director
Skills:
Drug Discovery
Pharmaceutical Industry
Drug Design
Drug Development
Clinical Development
Organic Synthesis
Immunology
Mark Player Photo 2

Senior Scientific Director And Fellow

View page
Location:
Phoenixville, PA
Industry:
Pharmaceuticals
Work:
3-Dimensional Pharmaceuticals Jan 1997 - Apr 2002
Senior Director

Johnson & Johnson Jan 1997 - Apr 2002
Senior Scientific Director and Fellow
Skills:
Drug Discovery
Pharmaceutical Industry
Drug Development
Drug Design
Clinical Development
Organic Synthesis
Immunology
Mark Player Photo 3

Managing Director

View page
Work:
Total Worldfresh
Managing Director
Mark Player Photo 4

Mark Player

View page
Mark Player Photo 5

Mark Player

View page

Publications

Us Patents

Quinazolinones

View page
US Patent:
6890930, May 10, 2005
Filed:
Sep 13, 2000
Appl. No.:
10/089166
Inventors:
Werner Mederski - Erzhausen, DE
Maria Devant - Darmstadt, DE
Gerhard Barnickel - Darmstadt, DE
Sabine Bernotat-Danielowski - Bad Nauheim, DE
Guido Melzer - Hofheim Ts, DE
Bertram Cezane - Moerfelden-Walldorf, DE
Dalijit Dhanoa - West Chester PA, US
James Rinker - Kenhurst PA, US
Mark Player - Phoenixville PA, US
Richard Soll - Lawrenceville NJ, US
Assignee:
3-Dimensional Pharmaceuticals, Inc. - Exton PA
International Classification:
A61K031/517
A61K031/505
C07D239/74
C07D239/72
US Classification:
5142662, 5142663, 51426631, 544283, 544284, 544287
Abstract:
Quinazolinones of formula (I) in which R, R, R, R, R, Y, Z, and m have the meaning indicated in patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists.

Quinazolinones

View page
US Patent:
7060706, Jun 13, 2006
Filed:
Sep 13, 2000
Appl. No.:
10/089167
Inventors:
Werner Mederski - Zwingenberg, DE
Ralf Devant - Darmstadt, DE
Gerhard Barnickel - Darmstadt, DE
Sabine Bernotat-Danielowski - Bad Nauheim, DE
Guido Melzer - Hofheim/Taunus, DE
Bertram Cezanne - Mörfelden-Walldorf, DE
Daljit Dhanoa - Del Mar CA, US
James Rinker - Kenhorst PA, US
Mark Player - Phoenixville PA, US
Richard Soll - Lawrencehill NJ, US
Assignee:
3-Dimensional Pharmaceuticals, Inc. - Exton PA
International Classification:
C07D 239/91
A61K 31/517
A61P 9/10
US Classification:
51426631, 544287
Abstract:
Quinazolinones of formula (I) in which R, R, R, R, R, Y, n and m have the meaning indicated in Patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists.

1,6 Naphthyridines Useful As Inhibitors Of Syk Kinase

View page
US Patent:
7321041, Jan 22, 2008
Filed:
Apr 15, 2003
Appl. No.:
10/413980
Inventors:
Charles L. Cywin - Bethel CT, US
Scott E. Jakes - Southbury CT, US
Joachim Heider - Warthausen, DE
Mark A. Bobko - Exton PA, US
Renee L. Des Jarlais - St. Davids PA, US
Mark Player - Phoenixville PA, US
James Rinker - Reading PA, US
Michael Winters - Lancaster PA, US
Assignee:
Boehringer Ingelheim Pharmaceuticals, Inc. - Ridgefield CT
International Classification:
C07D 471/02
US Classification:
546122
Abstract:
Disclosed are compounds of formula (I):.

Quinolinone Derivatives As Inhibitors Of C-Fms Kinase

View page
US Patent:
7326788, Feb 5, 2008
Filed:
Jul 20, 2004
Appl. No.:
10/894940
Inventors:
Mark J. Wall - Harleysville PA, US
Mark R. Player - Phoenixville PA, US
Raymond Joseph Patch - Yardley PA, US
Sanath Meegalla - Boothwyn PA, US
Jian Liu - Plainsboro NJ, US
Carl R. Illig - Phoenixville PA, US
Wing Cheung - Plainsboro NJ, US
Jinsheng Chen - Exton PA, US
Davoud Asgari - Newtown PA, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
C07D 215/38
C07D 215/44
US Classification:
546157, 546153
Abstract:
The invention is directed to compounds of Formulae I and II:.

C-Fms Kinase Inhibitors

View page
US Patent:
7427683, Sep 23, 2008
Filed:
Oct 22, 2004
Appl. No.:
10/970865
Inventors:
Mark R. Player - Phoenixville PA, US
Nand Baindur - Kendall Park NJ, US
Benjamin Brandt - Philadelphia PA, US
Naresh Chadha - Montville NJ, US
Raymond J. Patch - Yardley PA, US
Davoud Asgari - Plainsboro NJ, US
Taxiarchis Georgiadis - Carmel IN, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/454
C07D 401/12
US Classification:
546208, 514326
Abstract:
The invention is directed to compounds of Formulae I:.

C-Fms Kinase Inhibitors

View page
US Patent:
7429603, Sep 30, 2008
Filed:
Apr 26, 2004
Appl. No.:
10/831216
Inventors:
Mark R. Player - Phoenixville PA, US
Nand Baindur - Kendall Park NJ, US
Benjamin Brandt - Highland Park NJ, US
Naresh Chadha - Montville NJ, US
Raymond J. Patch - Yardley PA, US
Davoud Asgari - Plainsboro NJ, US
Taxiarchis M. Georgiadis - Carmel IN, US
Assignee:
3-Dimensional Pharmaceuticals, Inc. - Exton PA
International Classification:
C07D 405/02
A61K 31/445
US Classification:
514326, 514422, 546214, 548517
Abstract:
The invention is directed to compounds of Formulae I, II and III:.

Factor Xa Compounds

View page
US Patent:
7446210, Nov 4, 2008
Filed:
Oct 24, 2005
Appl. No.:
11/257208
Inventors:
Tianbao Lu - Churchville PA, US
Tho V. Thieu - Ambler PA, US
Yu-Kai Lee - Exton PA, US
Daniel J. Parks - Downingtown PA, US
Thomas P. Markotan - Morgantown PA, US
Wenxi Pan - Glenmore PA, US
Karen L. Milkiewicz - Exton PA, US
Mark R. Player - Phoenixville PA, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
C07D 207/00
C07D 213/00
C07D 231/00
C07D 231/54
C07D 239/02
C07D 241/04
C07D 265/28
C07D 295/00
C07D 487/00
US Classification:
5483581, 544 98, 544298, 544383, 546 1, 5483561, 548400
Abstract:
The present invention is directed to novel compounds of Formula I:.

4-Amino-Quinazolines

View page
US Patent:
7547702, Jun 16, 2009
Filed:
Sep 17, 2001
Appl. No.:
10/380908
Inventors:
Werner Mederski - Zwingenberg, DE
Maria Devant, legal representative - Darmstadt, DE
Gerhard Barnickel - Darmstadt, DE
Sabine Bernotat-Danielowski - Bad Neuheim, DE
James Vickers - Wolverhampton, GB
Bertram Cezanne - Moerfelden-Walldorf, DE
Daljit Dhanoa - Wakefield MA, US
James Rinker - Kenhurst PA, US
Mark R. Player - Phoenixville PA, US
Edward Jaegar - Trappe PA, US
Richard Soll - Lawrenceville NJ, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Rantan NJ
International Classification:
A61K 31/517
A61K 31/535
C07D 239/72
C07D 413/12
US Classification:
51425214, 51425217, 5142664, 5142358, 544293, 544116
Abstract:
Quinazolines of the formula (I) in which R, R, R, R, Rand Y have the meaning indicated in Patent claim , and their salts or solvates as glycoprotein bIX antagonists.
Mark R Player from Phoenixville, PA Get Report